TP53 and cancer: The activation of oncogenes (such as Myc, HIF-1α, and PI3K/Akt) and inactivation of tumor suppressors (such as p53, PTEN, TSC2 and LKB1) in cancer cells have been shown to contribute to metabolic alterations in cancer [23-25,35].